2017 Conference Evaluation Form

News


2018 PROGRAMME PRESENTATIONS HERE

2018 ABSTRACT BOOKLET AVAILABLE HERE

2018 EVALUATION QUESTIONNAIRE AVAILABLE HERE

2018 PROGRAMME HERE

This course provides 6 CPD Credits in accordance with the CPD Scheme of the Royal College of Radiologists.

2018 Conference Sponsors Below


Platinum Sponsor
BXTAccelyon Logo

Silver Sponsors
BD and BARD logo
Eckert and Ziegler Logo
Elekta Company Logo

Bronze Sponsors
Augmenix logo logo
Bayer logo
Janssen logo
mim Software Company Logo
SeeDos logo
Varian medical systems logo

Additional Sponsor
BK Ultrasound logo
Oncology Imaging Systems logo
 
 
 
 

2018 Prostate Brachytherapy Conference Evaluation Questionnaire

 

Many thanks for your attendance at the 2018 meeting. To enable us to process your certificate of attendance and to plan future meetings, please complete the following questionnaire.

 

1. About You - NB * are required fields
* Name:
* Position:
* Medical Establishment:
* Email:
* Postcode:
* GMC No: (if not applicable type N/A)
2. About the Meeting

Learning Objectives

 

In relation to brachytherapy for prostate cancer, participants will:

 

1. Understand the relative benefits of monotherapy.

2. Be informed of different approaches to managing intermediate and high risk prostate cancer.

3. Actively participate in discussions on salvage options post brachytherapy.

 

Please click the relevant boxes.
1. To what extent do you feel the meeting helped you to achieve the above learning outcomes?
Not at all 1 2 3 4 5 Completely
   
 
Please click the relevant boxes.
2. How would you rate the overall educational value of the meeting?
Poor 1 2 3 4 5 Excellent
   
 
3. Did the event meet with your expectations?
  Yes:   No:  
 
If no, please state why not.
 
3. How would you rate the educational value of each session?

Monotherapy

HDR Monotherapy in the UK – The first thousand
Poor 1 2 3 4 5 Excellent
   
 
LDR or HDR as monotherapy in low risk disease
Poor 1 2 3 4 5 Excellent
   
 
An alternative monotherapy – Are protons better? The US experience
Poor 1 2 3 4 5 Excellent
   
 

Managing intermediate and high risk prostate cancer

Androgen Deprivation in Brachytherapy – Adding efficacy or just toxicity
Poor 1 2 3 4 5 Excellent
   
How best to boost? A panel discussion
Poor 1 2 3 4 5 Excellent
   
LDR (including an update on Ascende RT)
Poor 1 2 3 4 5 Excellent
   
HDR
Poor 1 2 3 4 5 Excellent
   
 
IMRT
Poor 1 2 3 4 5 Excellent
   
 
Discussion
Poor 1 2 3 4 5 Excellent
   
 
Will PIVOTAL Boost give us the answers?
Poor 1 2 3 4 5 Excellent
   
 
Use of HDR and permanent seeds in prostate brachytherapy: Current practices and advances
Poor 1 2 3 4 5 Excellent
   
 

Breakout Sessions

Physicists / Radiographers - Real-world brachytherapy for physicists and radiographers
Poor 1 2 3 4 5 Excellent
   
 
After the cure: Imaging and side effects handling
Poor 1 2 3 4 5 Excellent
   
 

Poster Presentations

6 of the best
Poor 1 2 3 4 5 Excellent
   
 

Main Conference Continued...

 

Salvage post-brachytherapy – there is something we can offer?

Introduction – Can we have a consensus?
Poor 1 2 3 4 5 Excellent
   
 
What to image, how to do it and when
Poor 1 2 3 4 5 Excellent
   
 
Prostatectomy as salvage therapy
Poor 1 2 3 4 5 Excellent
   
 
LDR as salvage therapy
Poor 1 2 3 4 5 Excellent
   
 
HDR as salvage therapy
Poor 1 2 3 4 5 Excellent
   
 
Discussion: Can we come to an agreement?
Poor 1 2 3 4 5 Excellent
   
 
Medical Journals, do they have a future?
Poor 1 2 3 4 5 Excellent
   
 
4. Please rate the value of the meeting in terms of:
   a. Learning new information
Poor 1 2 3 4 5 Excellent
   
 
   b. Sharing best practice
Poor 1 2 3 4 5 Excellent
   
 
   c. Networking opportunity  
Poor 1 2 3 4 5 Excellent
   
 
   d. To what extent do you feel that this meeting will help you to improve your clinical practice?
Poor 1 2 3 4 5 Excellent
   
 
5. Please provide comments/suggestions for topics to include in future meetings or activities

Many thanks for your time